Literature DB >> 15078581

Pericarditis in myasthenia gravis.

Hemender S Vats1, Steven K Richardson, Satyavardhan Pulukurthy, Brian Olshansky.   

Abstract

Myasthenia gravis is an autoimmune disorder with antibodies to the acetylcholine receptors (Ach R) in skeletal muscles. Myocardial involvement can present as a myocarditis or with arrhythmias. To our knowledge, there is no documentation in the literature of pericardial involvement in myasthenia gravis. We report the presence of pericardial effusion and atrioventricular conduction block in a patient with myasthenia gravis that responded appropriately to immunosuppressive therapy and plasma exchanges.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078581     DOI: 10.1097/01.crd.0000117762.62596.8d

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  5 in total

1.  Takotsubo cardiomyopathy in myasthaenia gravis crisis confirmed by cardiac MRI.

Authors:  I B Harries; H Levoir; C Bucciarelli-Ducci; S Ramcharitar
Journal:  BMJ Case Rep       Date:  2015-09-28

2.  Left ventricular long-axis function in myasthenia gravis.

Authors:  Jone Furlund Owe; Einar Skulstad Davidsen; Geir Egil Eide; Eva Gerdts; Nils Erik Gilhus
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

3.  An Unfortunate Case of Takotsubo Cardiomyopathy During Plasmapheresis for Myasthenia Crisis.

Authors:  Abdullah Jahangir; Muhammad Rafay Khan Niazi; Syeda Sahra; Aneeqa Javed; Michael Krzyzak
Journal:  Cureus       Date:  2022-01-01

4.  Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis.

Authors:  Sarmad Said; Chad J Cooper; Haider Alkhateeb; Sherif Elhanafi; Jorge Bizet; Sucheta Gosavi; Zainul Abedin
Journal:  Am J Case Rep       Date:  2013-09-11

5.  Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases.

Authors:  Devarajan Rathish; Minuri Karalliyadda
Journal:  BMC Neurol       Date:  2019-11-12       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.